Market accessOfficial

Greek regulator EOF republishes corrected list of medicines with limited availability dated 31 October

🇬🇷 EOF · Mon 09 Nov 2026

The National Organisation for Medicines has issued a corrected repeat of its 31 October 2026 list of medicinal products with limited availability on the Greek market.

The Greek National Organisation for Medicines (EOF) has published a corrected repeat of its list of medicinal products with limited availability. The list carries the date 31 October 2026, and the republication was issued on 9 November 2026.

The source gives only the title of the document, which describes it as a corrected repeat. It does not say what was changed compared with the earlier version, and it does not name the products, active substances or companies concerned.

As general context, national medicines authorities in Europe publish shortage or limited-availability lists so that healthcare professionals, wholesalers and marketing authorisation holders can see which products are affected. Anyone relying on the original 31 October version should check the corrected document directly.

What it means for your team

  • Supply-chain and market-access teams active in Greece should consult the corrected EOF list and replace any copy of the earlier 31 October version.
  • Marketing authorisation holders should check whether their products appear on the list and whether their records match it.
  • QA and PV teams should note that the source does not specify what was corrected, so the full document is needed to identify any changes.

Official source: EOF ↗

Article written by VigiEye from the official source (EOF). AI-assisted; check the source before acting.

More Market access All →